Phibro Animal Health Corporation Releases Transcript of Q4 2025 Earnings Call
Phibro Animal Health Corporation recently held its Fourth Quarter and Fiscal Year 2025 Results Webcast and Conference Call, as detailed in a transcript released on August 28, 2025. The event was attended by key executives including Glenn C. David, Chief Financial Officer; Jack Clifford Bendheim, Chairman, President & CEO; Daniel M. Bendheim, Executive VP of Corporate Strategy & Director; and Larry L. Miller, Chief Operating Officer. Analysts from prominent firms such as JPMorgan Chase, Morgan Stanley, and BofA Securities participated in the call. During the session, Phibro's management discussed the company's financial performance for the fourth quarter and the full fiscal year ending June 30, 2025. CFO Glenn C. David expressed gratitude to the participants, stating, "Thank you, Regina, and thank you, everyone, for listening on today's call. We really appreciate your time, attention and interest and support of Phibro Animal Health." The management team highlighted the company's strategic initiatives and provided insights into future growth prospects. The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phibro Animal Health Corporation published the original content used to generate this news brief on September 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.